2026. The RE-UNITE-PN Study Design – A Prospective, Non-Interventional, Phase 4 Study of Nemolizumab for the Treatment of Prurigo Nodularis. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s767. DOI:https://doi.org/10.25251/q0ctfz86.